tirzepatide weight loss efficacy Tirzepatide: How it Works, Pros and Cons, Effectiveness FDA Approves Tirzepatide, A Potential

have severe digestive problems or a history of pancreatitis, have untreated diabetic eye disease

Current insight into the cardiovascular biology of GIP is limited, and findings in preclinical and clinical studies point in different directions, ranging from potentially cardioprotective effects to heightened vascular inflammation and artherogenesis 24,25

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition

This guide does that sorting for you

The estimates above are based on trial completion dates and standard regulatory timelines